West Pharmaceutical Services, Inc. logo
WSTWest Pharmaceutical Services, Inc.

Is the earnings yield high or low?

The earnings yield of 2.13% is 12% below its 5-year average of 2.41%, near the low end of its 5-year range (1.38%–3.97%).

As of Saturday, June 27, 2026. 17.76% below its 12-month average of 2.59%.

WST Earnings Yield

WST Earnings Yield Chart

2.13%
-26.80% 1Y
WST Earnings Yield

WST Average Earnings Yield Chart

WST Earnings Yield

WST Current vs Average Earnings Yield Chart

WST Earnings Yield Metrics

EARNINGS YIELD

2.13%

EARNINGS YIELD AVG TTM

2.59%

EARNINGS YIELD AVG 3Y

2.37%

EARNINGS YIELD AVG 5Y

2.41%

EARNINGS YIELD AVG 10Y

2.17%

EARNINGS YIELD AVG 15Y

2.64%

EARNINGS YIELD AVG 20Y

3.29%

CURRENT VS TTM AVG

-17.76%

CURRENT VS 3Y AVG

-10.24%

CURRENT VS 5Y AVG

-11.47%

CURRENT VS 10Y AVG

-2.04%

CURRENT VS 15Y AVG

-19.24%

CURRENT VS 20Y AVG

-35.34%

WST Competitors' Earnings Yield

NAMEMARKET CAPEARNINGS YIELDTTM3Y5Y
West Pharmaceutical Services, Inc. (WST)$24.79B2.13%2.59%2.37%2.41%
Waters Corporation (WAT)vs ›$24.41B2.10%3.16%3.29%3.36%
Mettler-Toledo International Inc. (MTD)vs ›$25.54B3.38%3.17%3.11%2.85%
Quest Diagnostics Incorporated (DGX)vs ›$23.08B4.39%4.59%4.87%6.61%
BioNTech SE (BNTX)vs ›$23.07BN/A8.30%19.01%16.60%
United Therapeutics Corporation (UTHR)vs ›$23.03B4.99%5.97%6.90%6.45%
Moderna, Inc. (MRNA)vs ›$26.69BN/A10.37%11.47%11.47%
Incyte Corporation (INCY)vs ›$22.73B6.22%5.60%3.38%3.64%
DexCom, Inc. (DXCM)vs ›$27.07B3.34%2.64%1.84%1.34%
Labcorp Holdings Inc. (LH)vs ›$22.26B4.16%3.75%3.33%5.99%

Earnings Yield vs P/E Ratio

Earnings Yield

2.13%

EPS ÷ Price

P/E Ratio

46.8

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

  • It expresses earnings relative to share price as a percentage
  • It can be compared with FCF yield and dividend yield
  • It can be compared with bond yields because both are percentages
  • It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Earnings Yield FAQ

What is the earnings yield for West Pharmaceutical Services, Inc. (WST)?
The earnings yield for WST stock is 2.13%.
Is West Pharmaceutical Services, Inc.'s earnings yield high or low?
The earnings yield of 2.13% is 12% below its 5-year average of 2.41%, near the low end of its 5-year range (1.38%–3.97%).
What is the TTM average earnings yield for West Pharmaceutical Services, Inc. (WST)?
The TTM average earnings yield for WST stock is 2.59%.
What is the 3Y average earnings yield for West Pharmaceutical Services, Inc. (WST)?
The 3Y average earnings yield for WST stock is 2.37%.
What is the 5Y average earnings yield for West Pharmaceutical Services, Inc. (WST)?
The 5Y average earnings yield for WST stock is 2.41%.
What is the 10Y average earnings yield for West Pharmaceutical Services, Inc. (WST)?
The 10Y average earnings yield for WST stock is 2.17%.
What is the 15Y average earnings yield for West Pharmaceutical Services, Inc. (WST)?
The 15Y average earnings yield for WST stock is 2.64%.
What is the 20Y average earnings yield for West Pharmaceutical Services, Inc. (WST)?
The 20Y average earnings yield for WST stock is 3.29%.

WST Earnings Yield History

DATEEARNINGS YIELD
2026-06-262.13%
2026-06-252.16%
2026-06-242.20%
2026-06-232.23%
2026-06-222.27%
2026-06-182.28%
2026-06-172.31%
2026-06-162.27%
2026-06-152.26%
2026-06-122.28%
2026-06-112.27%
2026-06-102.26%
2026-06-092.24%
2026-06-082.34%
2026-06-052.38%
2026-06-042.36%
2026-06-032.37%
2026-06-022.40%
2026-06-012.37%
2026-05-292.32%
2026-05-282.33%
2026-05-272.40%
2026-05-262.37%
2026-05-222.37%
2026-05-212.37%
2026-05-202.45%
2026-05-192.46%
2026-05-182.46%
2026-05-152.47%
2026-05-142.50%
2026-05-132.48%
2026-05-122.40%
2026-05-112.32%
2026-05-082.30%
2026-05-072.33%
2026-05-062.40%
2026-05-052.42%
2026-05-042.50%
2026-05-012.49%
2026-04-302.52%
2026-04-292.54%
2026-04-282.56%
2026-04-272.48%
2026-04-242.45%
2026-04-232.42%
2026-04-222.48%
2026-04-212.48%
2026-04-202.45%
2026-04-172.48%
2026-04-162.52%
2026-04-152.55%
2026-04-142.54%
2026-04-132.62%
2026-04-102.65%
2026-04-092.63%
2026-04-082.56%
2026-04-072.62%
2026-04-062.65%
2026-04-022.67%
2026-04-012.69%
2026-03-312.71%
2026-03-302.77%
2026-03-272.79%
2026-03-262.74%
2026-03-252.75%
2026-03-242.77%
2026-03-232.82%
2026-03-202.87%
2026-03-192.83%
2026-03-182.84%
2026-03-172.84%
2026-03-162.83%
2026-03-132.89%
2026-03-122.94%
2026-03-112.85%
2026-03-102.91%
2026-03-092.74%
2026-03-062.77%
2026-03-052.78%
2026-03-042.73%
2026-03-032.70%
2026-03-022.71%
2026-02-272.67%
2026-02-262.73%
2026-02-252.74%
2026-02-242.77%
2026-02-232.78%
2026-02-202.82%
2026-02-192.79%
2026-02-182.74%
2026-02-172.80%
2026-02-132.70%
2026-02-122.77%
2026-02-112.75%
2026-02-102.78%
2026-02-092.72%
2026-02-062.72%
2026-02-052.92%
2026-02-042.85%
2026-02-032.93%
2026-02-022.85%
2026-01-302.92%
2026-01-292.91%
2026-01-282.87%
2026-01-272.81%
2026-01-262.80%
2026-01-232.86%
2026-01-222.73%
2026-01-212.65%
2026-01-202.70%
2026-01-162.60%
2026-01-152.42%
2026-01-142.46%
2026-01-132.49%
2026-01-122.48%
2026-01-092.45%
2026-01-082.46%
2026-01-072.43%
2026-01-062.41%
2026-01-052.42%
2026-01-022.45%
2025-12-312.46%
2025-12-302.44%
2025-12-292.45%
2025-12-262.46%
2025-12-242.44%
2025-12-232.44%
2025-12-222.46%
2025-12-192.48%
2025-12-182.52%
2025-12-172.51%
2025-12-162.54%
2025-12-152.49%
2025-12-122.53%
2025-12-112.48%
2025-12-102.53%
2025-12-092.54%
2025-12-082.51%
2025-12-052.41%
2025-12-042.40%
2025-12-032.38%
2025-12-022.48%
2025-12-012.47%
2025-11-282.44%
2025-11-262.44%
2025-11-252.41%
2025-11-242.47%
2025-11-212.49%
2025-11-202.62%
2025-11-192.62%
2025-11-182.60%
2025-11-172.58%
2025-11-142.59%
2025-11-132.53%
2025-11-122.47%
2025-11-112.44%
2025-11-102.45%
2025-11-072.49%
2025-11-062.46%
2025-11-052.38%
2025-11-042.36%
2025-11-032.42%
2025-10-312.40%
2025-10-302.43%
2025-10-292.37%
2025-10-282.38%
2025-10-272.35%
2025-10-242.27%
2025-10-232.20%
2025-10-222.41%
2025-10-212.39%
2025-10-202.43%
2025-10-172.47%
2025-10-162.50%
2025-10-152.54%
2025-10-142.56%
2025-10-132.55%
2025-10-102.55%
2025-10-092.53%
2025-10-082.49%
2025-10-072.51%
2025-10-062.49%
2025-10-032.45%
2025-10-022.45%
2025-10-012.46%
2025-09-302.55%
2025-09-292.57%
2025-09-262.55%
2025-09-252.62%
2025-09-242.57%
2025-09-232.66%
2025-09-222.65%
2025-09-192.62%
2025-09-182.62%
2025-09-172.60%
2025-09-162.59%
2025-09-152.59%
2025-09-122.64%
2025-09-112.53%
2025-09-102.62%
2025-09-092.65%
2025-09-082.64%
2025-09-052.66%
2025-09-042.70%
2025-09-032.68%
2025-09-022.74%
2025-08-292.70%
2025-08-282.72%
2025-08-272.72%
2025-08-262.73%
2025-08-252.70%
2025-08-222.70%
2025-08-212.75%
2025-08-202.71%
2025-08-192.70%
2025-08-182.75%
2025-08-152.71%
2025-08-142.71%
2025-08-132.71%
2025-08-122.78%
2025-08-112.78%
2025-08-082.77%
2025-08-072.78%
2025-08-062.82%
2025-08-052.80%
2025-08-042.80%
2025-08-012.79%
2025-07-312.79%
2025-07-302.68%
2025-07-292.64%
2025-07-282.59%
2025-07-252.53%
2025-07-242.39%
2025-07-232.80%
2025-07-222.91%
2025-07-213.03%
2025-07-183.02%
2025-07-172.87%
2025-07-162.84%
2025-07-152.88%
2025-07-142.84%
2025-07-112.80%
2025-07-102.78%
2025-07-092.82%
2025-07-082.89%
2025-07-072.88%
2025-07-032.87%
2025-07-022.88%
2025-07-012.86%
2025-06-302.91%
2025-06-272.91%
2025-06-262.91%
2025-06-252.88%
2025-06-242.86%
2025-06-232.94%
2025-06-202.95%
2025-06-182.92%
2025-06-172.92%
2025-06-162.84%
2025-06-132.87%

Showing the most recent 260 of 5,032 data points. The chart above shows the full history.

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA
10,600 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green